Author:
Muntz James,Scott David A,Lloyd Adam,Egger Matthias
Abstract
Objectives: The frequency and consequences of major bleeding associated with anticoagulant prophylaxis for prevention of venous thromboembolism is examined.Methods: We conducted a systematic review and meta-analysis of controlled trials that reported rates of major bleeding after pharmaceutical thromboprophylaxis in patients undergoing major orthopedic surgery. Thromboprophylactic agents were divided into four groups:warfarin/other coumarin derivatives (WARF), unfractionated heparin (UFH), low molecular weight heparin (LMWH), and pentasaccharide (PS). Meta-analysis was conducted comparing LMWH with each of WARF, UFH, and PS. The frequency of re-operation due to major bleeding was reviewed and combined with published costs to estimate the mean cost of managing major bleeding events in these patients.Results: Twenty-one studies including 20,523 patients met inclusion criteria for the meta-analysis. No evidence of significant between-trial heterogeneity in risk ratios was found. Combined (fixed effects) relative risks (RR) of major bleeding compared with LMWH were WARF – RR 0.59 (95 percent confidence interval [CI], 0.44–0.80); UFH – RR 1.52 (95 percent CI, 1.04–2.23); PS – RR 1.52 (95 percent CI, 1.11–2.09). Seventy-one studies including 32,433 patients were included in the review of consequences of major bleeding. We estimated that the average cost of major bleeding is $113 per patient receiving thromboprophylaxis.Conclusions: LMWH results in fewer major bleeding episodes than UFH and PS but more than WARF. These events are costly and clinically important.
Publisher
Cambridge University Press (CUP)
Reference101 articles.
1. Turpie AG. 1991;Efficacy of a postoperative regimen of enoxaparin in deep vein thrombosis prophylaxis. Am J Surg.161:532–536.
2. Harris WH , Salzman EW , DeSanctis RW. 1967;The prevention of thromboembolic disease by prophylactic anticoagulation. A controlled study in elective hip surgery.J Bone Joint Surg Am.49:81–89.
3. Geerts WH , Heit JA , Clagett GP , et al.2001;Prevention of venous thromboembolism.Chest.119:132S–175S.
4. Dahl OE , Andreassen G , Aspelin T , et al.1997;Prolonged thromboprophylaxis following hip replacement surgery–results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin).Thromb Haemost.77:26–31.
5. Fitzgerald RHJ , Spiro TE , Trowbridge AA , et al.2001;Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.J Bone Joint Surg Am.83:900–906.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献